Stock A145720 DENTIUM CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Dentium CO., LTD

Equities

A145720

KR7145720009

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
112,200 KRW +0.72% Intraday chart for Dentium CO., LTD -1.23% -14.35%
May. 10 Dentium Q1 Profit Slides 9%; Shares Down 7% MT
2023 Dentium CO., LTD(KOSE:A145720) added to KOSPI 200 Index CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 463,965 354,442 601,948 862,389 1,129,730 967,601 - -
Enterprise Value (EV) 2 703 535.9 729.1 991.7 116,890 998.6 850.8 770.1
P/E ratio 23.9 x 15.8 x 10.8 x 10.1 x 11.7 x 10.9 x 9.46 x 7.74 x
Yield 0.28% 0.49% 0.36% - 0.31% 0.31% 0.34% 0.43%
Capitalization / Revenue 1.84 x 1.54 x 2.06 x 2.42 x 2.87 x 2.13 x 1.86 x 1.61 x
EV / Revenue 2.79 x 2.33 x 2.5 x 2.79 x 297 x 2.2 x 1.63 x 1.28 x
EV / EBITDA 11.3 x 9.86 x 8.77 x 6.94 x 734 x 5.78 x 4.23 x 3.36 x
EV / FCF -10.9 x 7.98 x 15.9 x -173 x 5,149 x 10.5 x 6.84 x 5.94 x
FCF Yield -9.14% 12.5% 6.3% -0.58% 0.02% 9.51% 14.6% 16.8%
Price to Book 2.19 x 1.55 x 2.06 x 2.31 x 2.43 x 2.06 x 1.77 x 1.32 x
Nbr of stocks (in thousands) 8,624 8,624 8,624 8,624 8,624 8,624 - -
Reference price 3 53,800 41,100 69,800 100,000 131,000 112,200 112,200 112,200
Announcement Date 2/27/20 2/23/21 3/22/22 2/28/23 2/28/24 - - -
1KRW in Million2KRW in Billions3KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 252.2 229.7 291.5 355.9 393.8 454.6 521.6 599.3
EBITDA 1 62.23 54.33 83.09 142.9 159.2 172.6 201.1 229.2
EBIT 1 47.92 39.6 69.88 124.4 131.9 152 179.9 209
Operating Margin 19% 17.23% 23.97% 34.95% 33.49% 33.44% 34.49% 34.87%
Earnings before Tax (EBT) 1 38.01 26.05 74.72 117.5 123.9 148.7 176.1 214.1
Net income 1 18.33 22.54 55.48 85.15 89.55 114.3 131.2 160.5
Net margin 7.27% 9.81% 19.03% 23.93% 22.74% 25.15% 25.16% 26.79%
EPS 2 2,250 2,595 6,434 9,873 11,193 10,320 11,855 14,500
Free Cash Flow 3 -64,236 67,140 45,932 -5,722 22,701 95,000 124,350 129,667
FCF margin -25,474.1% 29,223.07% 15,755.39% -1,608.01% 5,764.82% 20,898.81% 23,840.68% 21,636.35%
FCF Conversion (EBITDA) - 123,574.12% 55,280.69% - 14,262.74% 55,024.62% 61,846.44% 56,567.42%
FCF Conversion (Net income) - 297,807.54% 82,783.48% - 25,350.16% 83,102.49% 94,758.33% 80,772.43%
Dividend per Share 2 150.0 200.0 250.0 - 400.0 350.0 378.8 482.5
Announcement Date 2/27/20 2/23/21 3/22/22 2/28/23 2/28/24 - - -
1KRW in Billions2KRW3KRW in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 94.07 74.53 96.67 90.66 94.02 68.81 106.4 93.78 124.8 82.73 115.2 112.4 140.1
EBITDA 1 - - - 38.25 39.84 26.38 37.44 - - 25.43 47 41.3 54.8
EBIT 1 27.27 20.4 35.2 33.72 35.07 21.53 33.75 30.06 47.89 19.22 38.18 39.28 52
Operating Margin 28.99% 27.37% 36.41% 37.2% 37.3% 31.29% 31.73% 32.05% 38.37% 23.23% 33.13% 34.93% 37.12%
Earnings before Tax (EBT) 27.04 21.84 40.99 37.44 17.26 23.71 30.47 30.01 41.04 18.68 - - -
Net income 1 18.53 15.68 36.14 24.53 8.794 18.32 21.17 24.07 27.02 16.71 28.12 27.15 37.25
Net margin 19.7% 21.04% 37.39% 27.06% 9.35% 26.62% 19.9% 25.66% 21.65% 20.2% 24.41% 24.15% 26.59%
EPS - - - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - - -
Announcement Date 3/22/22 5/9/22 8/8/22 11/8/22 2/28/23 5/9/23 8/8/23 11/8/23 2/28/24 5/9/24 - - -
1KRW in Billions
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 239 181 127 129 115,761 31 - -
Net Cash position 1 - - - - - - 117 198
Leverage (Debt/EBITDA) 3.841 x 3.34 x 1.53 x 0.9048 x 727.3 x 0.1796 x - -
Free Cash Flow 2 -64,236 67,140 45,932 -5,722 22,701 95,000 124,350 129,667
ROE (net income / shareholders' equity) 9.03% 10.3% 21.7% 25.7% 23% 22.4% 20.9% 20.4%
ROA (Net income/ Total Assets) 3.71% 4.26% 10.3% 13.8% 13.3% 14% 13.9% 14.5%
Assets 1 494.1 528.7 540.2 615.7 671.9 819.5 946 1,105
Book Value Per Share 3 24,522 26,588 33,841 43,354 53,874 54,421 63,264 85,057
Cash Flow per Share 3 -1,513 8,727 8,594 5,451 7,536 14,992 17,193 19,782
Capex 1 51.2 8.62 28.2 52.7 42.3 26.6 33.3 30.2
Capex / Sales 20.3% 3.75% 9.67% 14.82% 10.74% 5.84% 6.38% 5.03%
Announcement Date 2/27/20 2/23/21 3/22/22 2/28/23 2/28/24 - - -
1KRW in Billions2KRW in Million3KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Dentium CO., LTD

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
112,200 KRW
Average target price
171,625 KRW
Spread / Average Target
+52.96%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Devices & Implants

1st Jan change Capi.
DENTIUM CO., LTD Stock Dentium CO., LTD
-14.35% 700M
STRYKER CORPORATION Stock Stryker Corporation
+13.73% 130B
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-8.17% 10.99B
GLAUKOS CORPORATION Stock Glaukos Corporation
+41.80% 5.67B
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
-21.94% 4.72B
AXONICS, INC. Stock Axonics, Inc.
+7.81% 3.42B
ENOVIS CORPORATION Stock Enovis Corporation
-10.26% 2.76B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-10.29% 2.11B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-13.58% 1.92B
DOUBLE MEDICAL TECHNOLOGY INC. Stock Double Medical Technology Inc.
-27.77% 1.68B
Medical Devices & Implants
  1. Stock Market
  2. Equities
  3. A145720 Stock
  4. Financials Dentium CO., LTD